Reports from Department of Hematology-Oncology Advance Knowledge in Breast Cancer (Bevacizumab in the neoadjuvant treatment of human epidermal growth factor receptor 2-negative breast cancer: A meta-analysis of randomized controlled trials)

Source :: Women's Health Weekly. March 28, 2019, 416
Publication Year :: 2019
Abstract: 2019 MAR 28 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Current study results on Oncology - Breast Cancer have been published. According to news [...]

Subjects :: Breast cancer -- Care and treatment -- Analysis
Epidermal growth factors -- Analysis
Cancer research -- Analysis
Adjuvant chemotherapy -- Analysis
Bevacizumab -- Product development -- Analysis
Women's health -- Analysis
Toxicity
Angiogenesis inhibitors
Antineoplastic agents
Editors
Health
Women's issues/gender studies

Tools